(Q47720829)

English

Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

quality of life

1 reference

based on heuristic

inferred from title

Brian G. Feagan

1

object named as

Brian G Feagan

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

Stefan Schreiber

5

object named as

Stefan Schreiber

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

Geoffroy Coteur

2

object named as

Geoffroy Coteur

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

Dorothy L Keininger

4

object named as

Dorothy L Keininger

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

author name string

Seng Tan

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

language of work or name

0 references

publication date

26 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

104

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

1976-1983

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

The quality of life in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Impact of inflammatory bowel disease on health-related quality of life

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Unemployment and disability in patients with moderately to severely active Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Burden of illness of Crohn's disease in Spain

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Certolizumab pegol for the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

SF-36 health survey update

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

EQ-5D: a measure of health status from the EuroQol Group

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Quality of life in relation to symptoms in patients with gastro‐oesophageal reflux disease — an analysis based on the ProGERD initiative

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Measuring health-related quality of life in patients with irritable bowel syndrome: can less be more?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Risks and benefits of infliximab for the treatment of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.199

21 January 2018

Identifiers

10.1038/AJG.2009.199

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19471252

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47720829&oldid=2167009205"